Advertisement
Advertisement
March 20, 2026
Peijia Medical’s DCwire Micro Guidewire Receives FDA Clearance
March 20, 2026—Peijia Medical, a China-based domestic medical device company focused on transcatheter valve therapeutics and neurovascular intervention markets, announced that its DCwire micro guidewire has received FDA 510(k) clearance.
Peijia Medical stated that the milestone represents the first FDA-cleared product in the company’s portfolio and underscores the company’s commitment to the field of neurointerventional medical devices. The clearance also enables its entry into the United States market as part of its global expansion strategy.
The company noted that the DCwire device was independently designed and developed by Achieva Medical Limited, a subsidiary of Peijia Medical.
Currently, the company has four transcatheter aortic valve replacement systems and approximately 20 neurointerventional devices commercialized in China and various product candidates at different stages of development, noted the press release.
Advertisement
Advertisement
